1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What Are the Most Profitable Therapies? Market Trends & Strategies Explained

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Topics under Therapy

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies (such as oncology) used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 26 000 reports

Global Therapy Market - Forecast

  • June 2016
    110 pages
  • Therapy  

    Anti-Infective  

    Digestive Syste...  

  • World  

    United States  

View report >

Therapy Market in the US

  • June 2016
    139 pages
  • United States  

View report >

Therapy Market in Canada and Europe

  • June 2016
    63 pages
  • Therapy  

    Cancer Hormonal...  

  • Canada  

    Europe  

View report >

Therapy Market and Mental Health Statistics in the US and Asia

  • April 2016
    25 pages
  • Therapy  

    Mental Health  

    Cigarette  

  • United States  

    Asia  

    North America  

View report >

Therapy Market in Japan

  • April 2016
    10 pages
  • Therapy  

    Therapy  

  • Japan  

View report >

Therapy Market in France

  • May 2016
    12 pages
  • Therapy  

    Urology  

  • France  

View report >

Therapy Market in Germany

  • June 2016
    14 pages
  • Therapy  

    Chemotherapy  

    Cancer  

  • Germany  

View report >

Therapy Market in Italy

  • February 2016
    5 pages
  • Targeted Therap...  

  • Italy  

View report >

Therapy Market in the UK

  • June 2016
    65 pages
  • Therapy  

    Monoclonal Anti...  

    Musculoskeletal...  

  • United Kingdom  

View report >

Therapy Market in Canada

  • June 2016
    35 pages
  • Therapy  

    Targeted Therap...  

    Chemotherapy  

  • Canada  

View report >


About 12 000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 23 500)

Immunodiagnostics Market: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Immunodiagnostics Market: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 23 500
  • Industry report
  • June 2016
  • by Venture Planning Group

VPGMarketResearch.com's new report is a strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial ...

Immunodiagnostics 2016-2020: Clinical Chemistry, Drugs ...

May 2016 $ 23 500

2016-2020 Poc/decentralized Diagnostic Testing Market: ...

May 2016 $ 16 600

Clinical Chemistry And Immunodiagnostics: France, Germa ...

June 2016 $ 12 800

Immunodiagnostics Market: France, Germany, Italy, Spain ...

June 2016 $ 12 800

Opportunity In The Indian Life Science Industry - 2016; ...

April 2016 $ 12 000

United Kingdom Hospital Supplies Market Outlook To 2021 ...

April 2016 $ 9 995

Copd: Kol Insight

April 2016 $ 8 085

Antimicrobial Packaging Market By Base Material, Antimi ...

May 2016 $ 9 000

Us Immunodiagnostics Market Analysis, Competitive Intel ...

June 2016 $ 7 500

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.